Article

A comparison of the molecular pharmacological properties of current short, long and ultra-long-acting β2-agonists used for asthma and COPD.

2025-04-25

Abstract excerpt

[1]¿p#1 Background and purpose β-agonists have been used in asthma for 120 years. There are two recent changes: ultra-long-acting agonists for COPD and new asthma guidelines recommending formoterol/ICS inhalers over short-acting salbutamol inhalers. Few studies directly compare the molecular pharmacological properties of short, long and ultra-long-acting β2-agonists. Experimental approach In vitro molecular pha...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: bd97c7c6-a077-5e67-b69e-59d8138073ed
DOI: 10.22541/au.174560615.57789698/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A comparison of the molecular pharmacological properties of current short, long and ultra-long-acting β2-agonists used for asthma and COPD.DOI 10.22541/au.174560615.57789698/v1Read

β2 Agonists.Semantic proximity Read

Controversies regarding long-acting β2-agonists.Semantic proximity Read

Pharmacogenetics of β2 adrenergic receptor gene polymorphisms, long-acting β-agonists and asthmaSemantic proximity Read

Safety and efficacy of beta agonists.Semantic proximity Read

Identification of Small Molecule as a High Affinity β2 Agonist Promiscuously Targeting Wild and Mutated (Thr164Ile) β 2 Adrenergic Receptor in the Treatment of Bronchial Asthma.Semantic proximity Read

Adverse effects of beta-agonists.Semantic proximity Read

Pharmacogenomics of beta2-agonist: key focus on signaling pathways.Semantic proximity Read

The beta-2 adrenergic receptor and its agonists.Semantic proximity Read

Pharmacogenomics of long-acting β2-agonists.Semantic proximity Read

Benefit-risk assessment of long-acting beta2-agonists in asthma.Semantic proximity Read

beta-Adrenergic receptor polymorphisms: relationship to the beta-agonist controversy and clinical implications.Semantic proximity Read

Pharmacogenetics of β2-AgonistsSemantic proximity Read